A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic ...

Preclinical research across multiple cancer types now shows that the NAD+ salvage pathway, the same biological mechanism targeted by popular anti-aging supplements like nicotinamide mononucleotide ...

The projections show the growing impact of lifestyle-related risk factors and gaps in early detection—while pointing to clear steps people can take now to reduce their risk. “These rising cancer rates ...

Pancreatic cancer is one of the most dangerous forms of cancer in the world. Many patients do not know they have the disease ...

Pancreatic cancer is one of the most dangerous forms of cancer in the world. It is known for being difficult to detect, spreading quickly, and resisting many treatments. Because the disease often ...

The federal government funds nearly 80% of all pancreatic cancer research. For pancreatic cancer — one of the deadliest ...

Namodenoson (CF102), an investigational small-molecule A3 adenosine receptor (A3AR) agonist, has demonstrated favorable ...

RASolute 302 Phase 3 catalyst, cash runway, and valuation risks for daraxonrasib. Read more macro analysis here.

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...

PanMETAI combines AI and NMR metabolomics to detect early-stage pancreatic cancer from a blood sample, achieving 93 percent ...

Treatment options for pancreatic neuroendocrine tumors (PNETs) have expanded considerably based on data from pivotal trials such as RADIANT-3 (NCT00510068), 1 Study A6181111 (NCT0 ...

More than 17,000 individuals with cancer died from their malignancy within a year of their diagnosis during the COVID-19 pandemic than expected based on previous trends.An evaluation of 1-year ...